These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 34602392)

  • 1. Influence of hs-CRP, IL-6 and TNF-α and it's role in dyslipidemia and type 2 diabetes in population of Karachi, Pakistan.
    Nisar M; Iqbal MU
    Pak J Pharm Sci; 2021 May; 34(3(Special)):1217-1225. PubMed ID: 34602392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CRP, but not TNF-α or IL-6, decreases after weight loss in patients with morbid obesity exposed to intensive weight reduction and balneological treatment.
    Rość D; Adamczyk P; Boinska J; Szafkowski R; Ponikowska I; Stankowska K; Góralczyk B; Ruszkowska-Ciastek B
    J Zhejiang Univ Sci B; 2015 May; 16(5):404-11. PubMed ID: 25990058
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The possible correlation between serum GRB2 levels and carotid atherosclerosis in patients with type 2 diabetes mellitus.
    Dong Y; Liu J; Ma J; Quan J; Bao Y; Cui Y
    Front Endocrinol (Lausanne); 2022; 13():963191. PubMed ID: 36176460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ADMA is a correlate of insulin resistance in early-stage diabetes independent of hs-CRP and body adiposity.
    Nakhjavani M; Karimi-Jafari H; Esteghamati A; Khalilzadeh O; Asgarani F; Ghadiri-Anari A
    Ann Endocrinol (Paris); 2010 Sep; 71(4):303-8. PubMed ID: 20434720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of n-3 PUFAs on postprandial variation of metalloproteinases, and inflammatory and insulin resistance parameters in dyslipidemic patients: evaluation with euglycemic clamp and oral fat load.
    Derosa G; Cicero AF; Fogari E; D'Angelo A; Bonaventura A; Romano D; Maffioli P
    J Clin Lipidol; 2012; 6(6):553-64. PubMed ID: 23312051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison between orlistat plus l-carnitine and orlistat alone on inflammation parameters in obese diabetic patients.
    Derosa G; Maffioli P; Ferrari I; D'Angelo A; Fogari E; Palumbo I; Randazzo S; Cicero AF
    Fundam Clin Pharmacol; 2011 Oct; 25(5):642-51. PubMed ID: 21077943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Components of the metabolic syndrome among a sample of overweight and obese Costa Rican schoolchildren.
    Holst-Schumacher I; Nuñez-Rivas H; Monge-Rojas R; Barrantes-Santamaría M
    Food Nutr Bull; 2009 Jun; 30(2):161-70. PubMed ID: 19689095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is serum C-reactive protein concentration correlated with HbA1c and insulin resistance in Type 2 diabetic men with or without coronary heart disease?
    Bahceci M; Tuzcu A; Ogun C; Canoruc N; Iltimur K; Aslan C
    J Endocrinol Invest; 2005 Feb; 28(2):145-50. PubMed ID: 15887860
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of C1q/TNF-related protein-3 (CTRP3) in serum of patients with gestational diabetes mellitus and its relationship with insulin resistance.
    Li JY; Wu GM; Hou Z; Cao YM
    Eur Rev Med Pharmacol Sci; 2017 Dec; 21(24):5702-5710. PubMed ID: 29272006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Obesity indices and metabolic markers are related to hs-CRP and adiponectin levels in overweight and obese females.
    Sanip Z; Ariffin FD; Al-Tahami BA; Sulaiman WA; Rasool AH
    Obes Res Clin Pract; 2013; 7(4):e315-20. PubMed ID: 24306161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of serum chemerin and inflammatory factors with type 2 diabetes macroangiopathy and waist-to-stature ratio.
    Yang M; Zhou X; Xu J; Yang B; Yu J; Gong Q; Zhang X; Sun X; Zhang Q; Xia J; Li J
    Bosn J Basic Med Sci; 2019 Nov; 19(4):328-335. PubMed ID: 31078135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma Periostin Levels Are Increased in Chinese Subjects with Obesity and Type 2 Diabetes and Are Positively Correlated with Glucose and Lipid Parameters.
    Luo Y; Qu H; Wang H; Wei H; Wu J; Duan Y; Liu D; Deng H
    Mediators Inflamm; 2016; 2016():6423637. PubMed ID: 27313402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of supervised aerobic training on dyslipidaemia among diabetic older patients.
    Alghadir AH; Gabr SA; Iqbal A
    BMC Endocr Disord; 2024 Oct; 24(1):212. PubMed ID: 39385223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variation of inflammatory parameters after sibutramine treatment compared to placebo in type 2 diabetic patients.
    Derosa G; Maffioli P; Ferrari I; Palumbo I; Randazzo S; D'Angelo A; Cicero AF
    J Clin Pharm Ther; 2011 Oct; 36(5):592-601. PubMed ID: 21070297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Visceral fat mass: is it the link between uric acid and diabetes risk?
    Seyed-Sadjadi N; Berg J; Bilgin AA; Grant R
    Lipids Health Dis; 2017 Jul; 16(1):142. PubMed ID: 28738905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Walnut-enriched diet reduces fasting non-HDL-cholesterol and apolipoprotein B in healthy Caucasian subjects: a randomized controlled cross-over clinical trial.
    Wu L; Piotrowski K; Rau T; Waldmann E; Broedl UC; Demmelmair H; Koletzko B; Stark RG; Nagel JM; Mantzoros CS; Parhofer KG
    Metabolism; 2014 Mar; 63(3):382-91. PubMed ID: 24360749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lipocalin-2 Levels, Insulin Resistance, and Urinary Albumin Excretion in Type 2 Diabetes Subgroups.
    Moon Y; Lee MH; Fujii N; Fujii T; Choi JW
    Clin Lab; 2023 Nov; 69(11):. PubMed ID: 37948484
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ramadan Intermittent Fasting Affects Adipokines and Leptin/Adiponectin Ratio in Type 2 Diabetes Mellitus and Their First-Degree Relatives.
    Abdullah K; Al-Habori M; Al-Eryani E
    Biomed Res Int; 2020; 2020():1281792. PubMed ID: 32775407
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Basal and postprandial plasma levels of PYY, ghrelin, cholecystokinin, gastrin and insulin in women with moderate and morbid obesity and metabolic syndrome.
    Zwirska-Korczala K; Konturek SJ; Sodowski M; Wylezol M; Kuka D; Sowa P; Adamczyk-Sowa M; Kukla M; Berdowska A; Rehfeld JF; Bielanski W; Brzozowski T
    J Physiol Pharmacol; 2007 Mar; 58 Suppl 1():13-35. PubMed ID: 17443025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of inflammatory markers in polycystic ovary syndrome: their relationship to insulin resistance and body mass index.
    Samy N; Hashim M; Sayed M; Said M
    Dis Markers; 2009; 26(4):163-70. PubMed ID: 19729797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.